Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Tag: GMP compliance

How MHRA GMP Supports the Manufacture of Orphan Drugs

Posted on December 23, 2024 By digi

How MHRA GMP Supports the Manufacture of Orphan Drugs Understanding the Role of MHRA GMP in Orphan Drug Manufacturing Introduction to Orphan Drugs and MHRA GMP Orphan drugs are pharmaceutical products developed specifically to treat rare diseases or conditions, often affecting a small patient population. Due to the complexities involved in their development and manufacturing,…

Read More “How MHRA GMP Supports the Manufacture of Orphan Drugs” »

MHRA GMP Guidelines

WHO GMP and the Importance of Training and Education for Compliance

Posted on December 22, 2024 By digi

WHO GMP and the Importance of Training and Education for Compliance The Role of Training and Education in Ensuring WHO GMP Compliance Introduction to WHO GMP and the Need for Training The World Health Organization (WHO)’s Good Manufacturing Practices (GMP)) are essential for ensuring the quality, safety, and efficacy of pharmaceutical products. Adhering to these…

Read More “WHO GMP and the Importance of Training and Education for Compliance” »

WHO GMP Guidelines

The Role of Sustainable Practices in TGA GMP Compliance

Posted on December 22, 2024 By digi

The Role of Sustainable Practices in TGA GMP Compliance How Sustainable Practices Enhance TGA GMP Compliance in Pharmaceutical Manufacturing Introduction to Sustainability and TGA GMP Compliance Sustainability is becoming a critical focus in the pharmaceutical industry, where environmental responsibility aligns with regulatory requirements like Good Manufacturing Practices (GMP). The Therapeutic Goods Administration (TGA) in Australia…

Read More “The Role of Sustainable Practices in TGA GMP Compliance” »

TGA GMP Guidelines

How ANVISA GMP Guidelines Promote Drug Quality in Brazil

Posted on December 22, 2024 By digi

How ANVISA GMP Guidelines Promote Drug Quality in Brazil How ANVISA GMP Guidelines Promote Drug Quality in Brazil Introduction to ANVISA and the Importance of GMP Guidelines The National Health Surveillance Agency (ANVISA) is the Brazilian regulatory body that ensures the safety, efficacy, and quality of pharmaceuticals in Brazil. As part of its mission to…

Read More “How ANVISA GMP Guidelines Promote Drug Quality in Brazil” »

GMP in Latin America (ANVISA, COFEPRIS)

PMDA GMP Compliance for Generic Drug Manufacturers

Posted on December 22, 2024 By digi

PMDA GMP Compliance for Generic Drug Manufacturers PMDA GMP Compliance for Generic Drug Manufacturers Introduction to PMDA GMP and Generic Drug Manufacturing Generic drugs play a crucial role in the pharmaceutical industry, providing affordable alternatives to branded medications while maintaining the same efficacy and safety profiles. However, ensuring the quality and safety of generic drugs…

Read More “PMDA GMP Compliance for Generic Drug Manufacturers” »

PMDA GMP Guidelines

The Importance of Documentation and Record Keeping for EMA GMP Compliance

Posted on December 22, 2024 By digi

The Importance of Documentation and Record Keeping for EMA GMP Compliance Ensuring EMA GMP Compliance Through Robust Documentation and Record Keeping Introduction to Documentation in EMA GMP Compliance Documentation and record keeping form the backbone of compliance with the European Medicines Agency (EMA)’s Good Manufacturing Practices (GMP)). These practices are essential for ensuring that pharmaceutical…

Read More “The Importance of Documentation and Record Keeping for EMA GMP Compliance” »

EMA GMP Guidelines

Best Practices for Ensuring NMPA GMP Compliance in Biopharmaceuticals

Posted on December 22, 2024 By digi

Best Practices for Ensuring NMPA GMP Compliance in Biopharmaceuticals Best Practices for Ensuring NMPA GMP Compliance in Biopharmaceuticals Introduction to NMPA GMP and Biopharmaceuticals Biopharmaceuticals, also known as biologics, are pharmaceutical products that are produced using biological systems. They include a wide range of therapies such as monoclonal antibodies, vaccines, gene therapies, and recombinant proteins….

Read More “Best Practices for Ensuring NMPA GMP Compliance in Biopharmaceuticals” »

NMPA GMP Guidelines

The Role of Training and Education in Achieving MHRA GMP Compliance

Posted on December 22, 2024 By digi

The Role of Training and Education in Achieving MHRA GMP Compliance How Training and Education Drive MHRA GMP Compliance in Pharmaceuticals Introduction to Training in MHRA GMP Compliance Achieving and maintaining compliance with the Medicines and Healthcare products Regulatory Agency (MHRA) Good Manufacturing Practices (GMP) is essential for pharmaceutical manufacturers to ensure the safety, quality,…

Read More “The Role of Training and Education in Achieving MHRA GMP Compliance” »

MHRA GMP Guidelines

The Impact of Schedule M (Revised) GMP on the Pharmaceutical Industry in India

Posted on December 22, 2024 By digi

The Impact of Schedule M (Revised) GMP on the Pharmaceutical Industry in India How Schedule M (Revised) GMP is Shaping the Pharmaceutical Industry in India Introduction to Schedule M (Revised) and Its Significance The pharmaceutical industry in India is one of the largest in the world, known for its high-quality generic medicines and affordable healthcare…

Read More “The Impact of Schedule M (Revised) GMP on the Pharmaceutical Industry in India” »

SCHEDULE - M - Revised

The Impact of WHO GMP on the Pharmaceutical Industry in Emerging Markets

Posted on December 22, 2024 By digi

The Impact of WHO GMP on the Pharmaceutical Industry in Emerging Markets How WHO GMP Standards Transform the Pharmaceutical Industry in Emerging Markets Introduction to WHO GMP and Emerging Markets Emerging markets are rapidly becoming significant players in the global pharmaceutical industry due to growing populations, increasing healthcare needs, and expanding manufacturing capabilities. However, these…

Read More “The Impact of WHO GMP on the Pharmaceutical Industry in Emerging Markets” »

WHO GMP Guidelines

Posts pagination

Previous 1 … 148 149 150 … 173 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2026 Pharma GMP.

Powered by PressBook WordPress theme